Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Fix the driver behind crashes, sound loss and screen glitches3Clear out junk files and repair common Windows errorsNovo Nordisk CEO Lars Fruergaard Jørgensen testified voluntarily before the Senate HELP Committee on September 24, 2024, after pressure from Sen. Bernie Sanders over the U.S. prices of Ozempic and Wegovy. The committee’s 2024 report cited monthly U.S. prices of $969 for Ozempic and $1,349 for Wegovy, but those were historical figures—not current prices or a measure of what every patient paid out of pocket.
What happened at the Senate hearing?
The Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing titled “Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?” on September 24, 2024. The hearing began at 10 a.m. in the Dirksen Senate Office Building. Jørgensen, then Novo Nordisk’s president and CEO, was the sole listed witness. The committee’s hearing page and the published hearing record document the event.
Sanders had announced on June 14, 2024, that Jørgensen had agreed to testify voluntarily after a subpoena vote was scheduled. Sanders said the committee would cancel the vote. The appearance followed political pressure, but it was not compelled by a subpoena. Sanders’s announcement describes the agreement.
What prices did Sanders and the committee challenge?
A Senate HELP Committee majority staff report published on September 24, 2024, listed monthly U.S. prices of $969 for Ozempic and $1,349 for Wegovy. It compared them with selected prices abroad. These are the report’s historical figures and comparisons, not independently verified current prices or patients’ out-of-pocket costs.
Free tools Windows power users keep installed
One-click scans. No signup required.
#1 Best Overall
- Premium Reusable Peptide Pen Injector –High-quality peptide pen designed for daily use. Durable, eco-friendly, and perfect as a reusable injection pen
- Precision Adjustable Dose Dial –Smooth, easy-to-read dial for accurate 1–60 unit dosing. Ensures reliable control
- Wide Compatibility with 3ml Cartridges –Fits most standard 3ml cartridges securely. Works with reusable injection pens and peptide pen systems for flexible use
- Enhanced V3 Internal Mechanism –Upgraded internal design provides smoother rotation and long-lasting durability
- Portable & Protective Design – Compact, lightweight pen with protective case included. Perfect for travel, home use
| Medicine | U.S. monthly price cited by committee staff | Selected prices cited by committee staff |
|---|---|---|
| Ozempic | $969 | Germany: $59; France: $71; Denmark: $122; Canada: $155 |
| Wegovy | $1,349 | United Kingdom: $92; Germany: $137; Denmark: $186; Canada: $265 |
All amounts in the table are the monthly prices reported by Senate HELP majority staff in 2024. The report’s figures should not be read as a present-day price quote, a like-for-like estimate of every patient’s cost, or a guarantee of what a person would pay in any country. The committee’s report contains its comparisons and definitions.
Before the hearing, Sanders framed the disparity as a question of fairness: “The Committee looks forward to Mr. Jørgensen answering a very simple question: Why does he think it’s acceptable to charge Americans up to 10 or 15 times more for Ozempic and Wegovy than people in Europe and other major countries?” That was Sanders’s statement ahead of the hearing, not a finding that every U.S. patient paid 10 or 15 times what every overseas patient paid. The committee’s report also said that 194 million Americans had insurance that did not cover the drugs, citing a 2024 database it described as representing nearly 88% of covered U.S. lives. That estimate reflects the report’s account of the database, not a count of uninsured people.
Rank #2
- Reusable: This injection pen is designed for multiple uses, eliminating the need for disposable syringes.
- Convenient: With its compact size and user-friendly design, it offers a hassle-free injection experience.
- Precise Dosing: The pen allows for accurate and controlled medication delivery, ensuring proper dosage.
- Customizable: Adjustable dose settings cater to individual needs, providing flexibility in treatment.
- Portable: Its lightweight and discreet design make it easy to carry and use on-the-go.
Why list price is not the same as what a patient pays
The disagreement is easier to understand when four different price and access concepts are separated:
- List price: The stated price before discounts or rebates. The committee’s U.S. figures were presented as monthly prices; they do not establish an individual’s final bill.
- Net price: The amount a manufacturer says it receives after applicable discounts and rebates. This is not necessarily disclosed in a way that maps directly to a patient’s cost.
- Insurance coverage: Whether a plan covers a medicine, and under what conditions. A covered drug may still involve cost sharing or eligibility requirements; lack of coverage can leave a patient facing a different price.
- Out-of-pocket cost: What a particular patient pays, which can depend on insurance, coverage rules, and the patient’s circumstances.
As a result, a high list price can be relevant to people without coverage while not matching the copay reported by some insured patients. Conversely, a company’s average or selected copay claim does not show that everyone can obtain coverage or afford treatment.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteRank #3
- PRECISION 1-80 UNIT CONTROL - Designed for stable, repeatable adjustment, this injection pen features a smooth dial that lets you set the dose in 1-unit increments from 1 to 80 units. The reverse-rotation structure helps reduce accidental over-adjustment and supports clearer, more consistent dose management during repeated use. Easy-to-read markings make it simpler to track volume changes, routine planning, and step-by-step operation whether at home or on the go with cleaner repeat handling
- REUSABLE DURABLE BUILD WITH PROFESSIONAL FEEL - Constructed with a durable engineering-grade housing for long-lasting everyday use, the pen feels solid in hand and is designed for repeated use rather than one-time disposal. The balanced design provides a comfortable grip, controlled handling, and reliable everyday operation. Its blue finish gives the pen a clean, premium look, while the sturdy construction is designed to withstand frequent adjustment, transport, and storage for everyday or travel use
- COMPATIBLE WITH STANDARD 3ML CARTRIDGE SYSTEMS - This pen injector is designed for broad compatibility with most standard 3ml cartridges using an 11 mm long piston format, giving you more flexibility when setting up your preferred cartridge workflow. The set also includes 5 empty 3ml cartridges, making it easier to organize replacements, preparation steps, or routine rotation. Please verify cartridge size and structure before use to ensure a proper fit with your specific setup across different workflows
- PORTABLE CASE AND ORGANIZED STORAGE - The complete set includes 1 reusable injection pen, 5 empty 3ml cartridges, and 1 protective carry case for cleaner everyday organization. The case features a dedicated holder for one cartridge plus three extra accessory slots, helping keep components sorted for home storage, travel bags, backpacks, or desk drawers. The compact layout supports quick packing, convenient transport, and better day-to-day management without taking up much space during daily routines
- QUALITY CHECKED WITH RESPONSIVE SUPPORT - Each pen is inspected before shipment to help support stable structure, smooth adjustment, and dependable overall condition on arrival. If you have questions about setup, compatibility, or general product use, our customer support team is ready to provide fast and reliable assistance. We focus on clear communication, responsible service, and a better long-term ownership experience so you can order with more confidence and get help quickly whenever needed
What Novo Nordisk said in response
In his written testimony for the hearing, Jørgensen offered a different affordability frame. He said Novo Nordisk’s U.S. net price for Ozempic had fallen about 40% since its 2018 introduction, defining net price as the amount the company is actually paid. He also said more than 80% of insured U.S. patients with coverage for Ozempic or Wegovy paid $25 or less per prescription. These were company claims in his testimony, not independent estimates of what every patient pays.
“Since Ozempic® was first introduced in 2018, the net price—the amount that Novo Nordisk is actually paid for our medicines—has declined by about 40 percent in the U.S.”
Rank #4
V2 Reusable Injection Pen Set, 5 Pens with 5 Bonus Cartridges, 60 Unit Peptide Pen Injector with Adjustable Dose Dial (Black, Green, Blue, Gold, Purple)
- Premium Reusable Peptide Injection Pen: This 60 unit reusable injection pen features a durable metal body designed for repeated use. The sturdy construction and comfortable grip provide a premium feel while combining durability with everyday practicality
- Precise Dose Control & Clear Display: Peptide pen features a smooth two-way dial and a clear display window. Easy-to-read markings make adjustments simple and intuitive for convenient everyday handling
- Broad Compatibility: Pen injector is compatible with commonly used standard 3 mL cartridges and includes five empty 3 mL cartridges for added convenience and flexible setup
- Enhanced Sealing Design: Auto injector pen for peptides features an optimized sealing structure designed to provide a secure fit and help minimize air exposure. The simple assembly and sturdy construction make handling more convenient
- Compact & Portable Design: This pen features a lightweight, compact design with an ergonomic grip for comfortable handling. Its pocket-friendly size makes it convenient to carry in a bag or storage case
Jørgensen also argued that the complexity of the U.S. healthcare system reduced access and affordability for many people. His testimony therefore did not simply dispute the reported list prices; it emphasized net prices, insurance coverage, and the gap between a manufacturer’s price and an insured patient’s copay. His written testimony sets out the company’s position.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the committee said about insurers and pharmacy benefit managers
Sanders and the HELP majority staff argued that insurers and pharmacy benefit managers (PBMs) were not the reason for the drugs’ list prices. The committee’s September 2024 report said all three major PBMs had committed that lowering the list prices would not negatively affect Ozempic and Wegovy’s placement on their formularies. That is the committee’s account of the PBMs’ commitments, not a guarantee about every plan’s coverage decisions or an independent resolution of the broader pricing debate. The report describes the committee’s position.
Best Value
- Reusable: This injection pen is designed for multiple uses, eliminating the need for disposable syringes.
- Convenient: With its compact size and user-friendly design, it offers a hassle-free injection experience.
- Precise Dosing: The pen allows for accurate and controlled medication delivery, ensuring proper dosage.
- Customizable: Adjustable dose settings cater to individual needs, providing flexibility in treatment.
- Portable: Its lightweight and discreet design make it easy to carry and use on-the-go.
What the hearing does—and does not—tell patients now
The hearing establishes that Congress publicly challenged Novo Nordisk over the U.S. pricing of Ozempic and Wegovy, and that the company defended its approach using net-price and insured-patient cost claims. It does not establish what either medicine costs in 2026, whether a specific insurance plan covers it, or what a particular patient would pay today. Anyone making a current treatment or budgeting decision needs current pricing and coverage information from the relevant insurer, pharmacy, or prescriber rather than relying on a 2024 committee comparison.
Sanders had launched the committee investigation on April 24, 2024. His announcement set out the inquiry that led to the hearing.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
